A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone

A Case Report of Leptomeningeal Myelomatosis and Rapid Improvement with Regimen Consisting of Daratumumab, Pomalidomide, Vincristine, Procarbazine, and Dexamethasone

Central nervous system (CNS) involvement in multiple myeloma (MM) (MM-CNS) in the form of leptomeningeal myelomatosis or brain parenchyma plasmacytoma is rare, causing challenges in clinical diagnosis and treatment. We would like to report a case of leptomeningeal myelomatosis and illustrated the ch...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jew Win Kuan, Sing Ling Chai, Pathmanathan Rajadurai, Lee Gong Lau, Joseph Uchang, Sharifah Noor Akmal Syed Husain
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Case Reports in Hematology
Online Access:	http://dx.doi.org/10.1155/2022/4081971
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Daratumumab, Lenalidomide, and Dexamethasone (DRD), an Active Regimen in the Treatment of Immunosuppression-Associated Plasmablastic Lymphoma (PBL) in the Setting of Gorham’s Lymphangiomatosis: Review of the Literature
by: Matthew Lee, et al.
Published: (2022-01-01)

MRD-driven phase 2 study of daratumumab, carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma
by: Manisha Bhutani, et al.
Published: (2025-02-01)

Dural Plasmacytoma with Meningeal Myelomatosis in a Patient with Multiple Myeloma
by: Nieves Gascón, et al.
Published: (2018-01-01)

Overview of the evaluation of the destructive effect of procarbazine on the ovarian reserve in the apoptotic, inflammatory, and oxidative pathways
by: Kezban Kartlasmis, et al.
Published: (2024-12-01)

Daratumumab for autoimmune diseases: a systematic review
by: Martin Krusche, et al.
Published: (2023-12-01)

Leptomeningeal Enhancement due to Neurosarcoidosis Mimicking Malignancy
by: Sahara N. Saltijeral, et al.
Published: (2020-01-01)

Primary Diffuse Leptomeningeal Gliomatosis: Radiological/Pathological Features
by: Ehtasham Ahmad, et al.
Published: (2016-01-01)

High Performance Liquid Chromatographic Assay for the Simultaneous Determination of Posaconazole and Vincristine in Rat Plasma
by: Hadeel A. Khalil, et al.
Published: (2015-01-01)

Acute Hydrocephalus due to Secondary Leptomeningeal Dissemination of an Anaplastic Oligodendroglioma
by: Andreas M. Stark, et al.
Published: (2009-01-01)

A case of leptomeningeal metastasis originating from lung adenocarcinoma
by: Jiadong Song, et al.
Published: (2025-02-01)

Is There a Role for Daratumumab Retreatment in Patients with Relapsed/Refractory Multiple Myeloma?
by: Davor Galusic, et al.
Published: (2025-01-01)

A review on intrathecal administration of medications for leptomeningeal metastases in solid tumors
by: Xuemei Wang, et al.
Published: (2025-02-01)

Bilateral Bulky Adrenal Plasmacytomas with Very Good Response to Daratumumab-Based Therapy
by: Fang-Yu Wang, et al.
Published: (2023-04-01)

Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose
by: Nao Iguchi, et al.
Published: (2024-07-01)

Using Network Pharmacology and Animal Experiment to Investigate the Therapeutic Mechanisms of Polydatin against Vincristine-Induced Neuropathic Pain
by: Peng Xi, et al.
Published: (2022-01-01)

Daratumumab improves the hematological response and kidney function of patients with light chain deposition disease
by: Xin Zhang, et al.
Published: (2025-01-01)

Leptomeningeal Dissemination in Choroid Plexus Tumors: Magnetic Resonance Imaging Appearance and Risk Factors
by: Daniel Nunes do Espirito Santo, et al.
Published: (2025-01-01)

Refractory IgD Multiple Myeloma Treated with Daratumumab: A Case Report and Literature Review
by: Muhammad Husnain, et al.
Published: (2016-01-01)

Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
by: Nu T. Lu, et al.
Published: (2015-09-01)

Leptomeningeal Cells Transduce Peripheral Macrophages Inflammatory Signal to Microglia in Reponse to Porphyromonas gingivalis LPS
by: Yicong Liu, et al.
Published: (2013-01-01)

Author Correction: Lower urinary dysfunction as a long-term effect of childhood vincristine treatment, with potential influences by sex and dose
by: Nao Iguchi, et al.
Published: (2025-02-01)

Vincristine Regulates C/EBP-β/TGF-β1 to Promote A1 Astrocyte Polarization and Induce Neuropathic Pain
by: Chen Y, et al.
Published: (2025-02-01)

Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries
by: Anas Hamad, et al.
Published: (2024-07-01)

Daratumumab for Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allograft: A Case Report
by: Zewei Chen, et al.
Published: (2025-02-01)

A Case of Diffuse Leptomeningeal Glioneuronal Tumor Misdiagnosed as Chronic Tuberculous Meningitis without Brain Biopsy
by: Jung-goo Lee, et al.
Published: (2018-01-01)

Salvage Therapy in Early Relapse of T-Lymphoblastic Leukemia/Lymphoma Using Daratumumab/Nelarabine Combination: Two Consecutive Cases
by: Ingolf Molle, et al.
Published: (2022-01-01)

Epstein–Barr Virus Driven Hodgkin’s Lymphoma after a Short Course of Daratumumab Treatment for Relapsed Multiple Myeloma
by: Moeen Mohammadi-Oroujeh, et al.
Published: (2023-01-01)

A rare case of vision loss caused by leptomeningeal metastasis of lung adenocarcinoma: a case report and literature review
by: Zhihua Li, et al.
Published: (2025-02-01)

Bortezomib, thalidomide, and dexamethasone versus thalidomide and dexamethasone for response rates in multiple myeloma patients: a retrospective study
by: Juan M. Cano-Calderón, et al.
Published: (2025-01-01)

Surgical Management of Complications after Dexamethasone Implant
by: Giancarlo Sborgia, et al.
Published: (2020-01-01)

Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis
by: Sheng-Kai Liang, et al.
Published: (2025-02-01)

Exploratory profiling of metabolites in cerebrospinal fluid using a commercially available targeted LC-MS based metabolomics kit to discriminate leptomeningeal metastasis
by: Soojin Jang, et al.
Published: (2025-01-01)

Effectiveness of nefopam-dexamethasone versus pethidine-dexamethasone for postoperative pain management in cesarean sections: a double-blind, prospective clinical trial
by: Julian Ojebo, et al.
Published: (2024-04-01)

Investigation of the Proliferation, Apoptosis/Necrosis, and Cell Cycle Phases in Several Human Multiple Myeloma Cell Lines. Comparison of Viscum album QuFrF Extract with Vincristine in an In Vitro Model
by: Eva Kovacs
Published: (2010-01-01)

Splitting of a Dexamethasone Implant (Ozurdex) following the Injection
by: Oya Donmez, et al.
Published: (2013-01-01)

Favorable Outcome of Ramsay Hunt Syndrome under Dexamethasone
by: Josef Finsterer, et al.
Published: (2012-01-01)

The effectiveness of dexamethasone as a combination therapy for COVID-19
by: Namazi Nader
Published: (2022-09-01)

Bortezomib, thalidomide, and dexamethasone versus bortezomib, lenalidomide, and dexamethasone in transplant-eligible newly diagnosed multiple myeloma: a systemic review and meta-analysis
by: Yin-Che Wang, et al.
Published: (2025-12-01)

Daratumumab treatment for kidney-involved light chain deposition disease prevents renal function progression: a case report with 3 years of follow-up and review of the literature
by: Xueying Chen, et al.
Published: (2025-01-01)

Randomised Trial: Adrenaline & Dexamethasone Vs. Adrenaline In Children With Bronchiolitis
by: Sidra Choudhary, et al.
Published: (2024-12-01)